Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Haegebarth, Andrea

Class:IdPerson:4640960
_displayNameHaegebarth, Andrea
_timestamp2013-09-27 21:10:39
created[InstanceEdit:4640959] Rothfels, K, 2013-09-27
firstnameAndrea
initialA
surnameHaegebarth
(author)[LiteratureReference:4641124] Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
[LiteratureReference:5246636] Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl
[LiteratureReference:5340568] The Intestinal Wnt/TCF Signature
[LiteratureReference:8849033] The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2
[LiteratureReference:9732490] BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models
[Change default viewing format]
No pathways have been reviewed or authored by Haegebarth, Andrea (4640960)